Cargando…
Antibody response to SARS-CoV-2 vaccination or infection in a prospective cohort of children with neuroinflammatory diseases
INTRODUCTION: Immune medications affect antibody responses to SARS-CoV-2 vaccination in adults with neuroinflammatory disorders, but little is known about antibody responses in children with neuroinflammation and on immune treatments. Here we measure antibody levels in response to SARS-CoV-2 vaccina...
Autores principales: | Kaufmann, Charlotte, Morris, Morgan, Gombolay, Grace Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Paediatric Neurology Society. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307668/ https://www.ncbi.nlm.nih.gov/pubmed/37399703 http://dx.doi.org/10.1016/j.ejpn.2023.06.009 |
Ejemplares similares
-
Immune responses to SARS‐CoV‐2 vaccination in multiple sclerosis: a systematic review/meta‐analysis
por: Gombolay, Grace Y., et al.
Publicado: (2022) -
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
por: Epstein, Samantha, et al.
Publicado: (2022) -
The neuroinflammatory pathways of post-SARS-CoV-2 psychiatric disorders
por: Fond, G., et al.
Publicado: (2021) -
Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19
por: Ngo, Binh, et al.
Publicado: (2021) -
240 Neurologic complications in children with seizures and respiratory illness: A comparison between SARS-CoV-2 and other respiratory viruses
por: Gombolay, Grace, et al.
Publicado: (2022)